Introduction of Vasculature in Engineered Three-dimensional Tissue

Overview

Journal Inflamm Regen

Publisher Biomed Central

Date 2017 Dec 21

PMID 29259724

Citations 8

Authors

Sachiko Sekiya

Tatsuya Shimizu

Affiliations

Soon will be listed here.

Abstract

Background: With recent developments in tissue engineering technology, various three-dimensional tissues can be generated now. However, as the tissue thickness increases due to three-dimensionalization, it is difficult to increase the tissue scale without introduction of blood vessels.

Main Text: Many methods for vasculature induction have been reported recently. In this review, we introduced several methods which are adjustable vascularization in three-dimensional tissues according to three steps. First, "selection" provides potents for engineered tissues with vascularization ability. Second, "assembly technology" is used to fabricate tissues as three-dimensional structures and simultaneously inner neo-vasculature. Third, a "perfusion" technique is used for maturation of blood vessels in three-dimensional tissues. In "selection", selection of cells and materials gives the ability to promote angiogenesis in three-dimensional tissues. During the cell assembly step, cell sheet engineering, nanofilm coating technology, and three-dimensional printing technology could be used to produce vascularized three-dimensional tissues. Perfusion techniques to perfuse blood or cell culture medium throughout three-dimensional tissues with a unified inlet and outlet could induce functional blood vessels within retransplantable three-dimensional tissues. Combination of each step technology allows simulation of perivascular microenvironments in target tissues and drive vascularization in three-dimensional tissues.

Conclusion: The biomimetic microenvironment of target tissues will induce adequate cell-cell interaction, distance, cell morphology, and function within tissues. It could be accelerated for vascularization within three-dimensional tissues and give us the functional tissues. Since vascularized three-dimensional tissues are highly functional, they are expected to contribute to the development of regenerative medicine and drug safety tests for drug discovery in the future.

Citing Articles

Temperature-modulated separation of vascular cells using thermoresponsive-anionic block copolymer-modified glass.

Hirotani T, Nagase K Regen Ther. 2024; 27:259-267.

PMID: 38601885 PMC: 11004074. DOI: 10.1016/j.reth.2024.03.009.

Current methods for fabricating 3D cardiac engineered constructs.

Rogozinski N, Yanez A, Bhoi R, Lee M, Yang H iScience. 2022; 25(5):104330.

PMID: 35602954 PMC: 9118671. DOI: 10.1016/j.isci.2022.104330.

Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models.

Kennedy C, Brown E, Abutaleb N, Truskey G Front Cardiovasc Med. 2021; 8:625016.

PMID: 33659279 PMC: 7917070. DOI: 10.3389/fcvm.2021.625016.

Synergistic effects of laminin-1 peptides, VEGF and FGF9 on salivary gland regeneration.

Nam K, Dean S, Brown C, Smith Jr R, Lei P, Andreadis S Acta Biomater. 2019; 91:186-194.

PMID: 31028910 PMC: 6534356. DOI: 10.1016/j.actbio.2019.04.049.

Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism.

Ulmer B, Eschenhagen T Biochim Biophys Acta Mol Cell Res. 2019; 1867(3):118471.

PMID: 30954570 PMC: 7042711. DOI: 10.1016/j.bbamcr.2019.04.001.

References

Tayalia P, Mooney D . Controlled growth factor delivery for tissue engineering. Adv Mater. 2010; 21(32-33):3269-85. DOI: 10.1002/adma.200900241. View

Haraguchi Y, Shimizu T, Sasagawa T, Sekine H, Sakaguchi K, Kikuchi T . Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro. Nat Protoc. 2012; 7(5):850-8. DOI: 10.1038/nprot.2012.027. View

Roh J, Sawh-Martinez R, Brennan M, Jay S, Devine L, Rao D . Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010; 107(10):4669-74. PMC: 2842056. DOI: 10.1073/pnas.0911465107. View

Sekine H, Shimizu T, Sakaguchi K, Dobashi I, Wada M, Yamato M . In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun. 2013; 4:1399. PMC: 3660653. DOI: 10.1038/ncomms2406. View

Faulk D, Carruthers C, Warner H, Kramer C, Reing J, Zhang L . The effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomater. 2013; 10(1):183-93. PMC: 3857635. DOI: 10.1016/j.actbio.2013.09.006. View

Colton C . Implantable biohybrid artificial organs. Cell Transplant. 1995; 4(4):415-36. DOI: 10.1177/096368979500400413. View

Langer R, Vacanti J . Tissue engineering. Science. 1993; 260(5110):920-6. DOI: 10.1126/science.8493529. View

Nau C, Henrich D, Seebach C, Schroder K, Fitzsimmons S, Hankel S . Treatment of Large Bone Defects with a Vascularized Periosteal Flap in Combination with Biodegradable Scaffold Seeded with Bone Marrow-Derived Mononuclear Cells: An Experimental Study in Rats. Tissue Eng Part A. 2015; 22(1-2):133-41. DOI: 10.1089/ten.TEA.2015.0030. View

Cheng G, Liao S, Wong H, Lacorre D, Tomaso E, Au P . Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. Blood. 2011; 118(17):4740-9. PMC: 3208287. DOI: 10.1182/blood-2011-02-338426. View

10.

Sekiya S, Muraoka M, Sasagawa T, Shimizu T, Yamato M, Okano T . Three-dimensional cell-dense constructs containing endothelial cell-networks are an effective tool for in vivo and in vitro vascular biology research. Microvasc Res. 2010; 80(3):549-51. DOI: 10.1016/j.mvr.2010.08.001. View

11.

Bersini S, Yazdi I, Talo G, Shin S, Moretti M, Khademhosseini A . Cell-microenvironment interactions and architectures in microvascular systems. Biotechnol Adv. 2016; 34(6):1113-1130. PMC: 5003740. DOI: 10.1016/j.biotechadv.2016.07.002. View

12.

Tsuda Y, Shimizu T, Yamato M, Kikuchi A, Sasagawa T, Sekiya S . Cellular control of tissue architectures using a three-dimensional tissue fabrication technique. Biomaterials. 2007; 28(33):4939-46. DOI: 10.1016/j.biomaterials.2007.08.002. View

13.

Horikoshi-Ishihara H, Tobita M, Tajima S, Rica Tanaka , Oshita T, Tabata Y . Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model. J Vasc Surg. 2015; 64(6):1825-1834.e1. DOI: 10.1016/j.jvs.2015.09.054. View

14.

Sasagawa T, Shimizu T, Sekiya S, Yamato M, Okano T . Comparison of angiogenic potential between prevascular and non-prevascular layered adipose-derived stem cell-sheets in early post-transplanted period. J Biomed Mater Res A. 2013; 102(2):358-65. DOI: 10.1002/jbm.a.34707. View

15.

Zhou X, Hu J, Li J, Shi J, Chen Y . Patterning of two-level topographic cues for observation of competitive guidance of cell alignment. ACS Appl Mater Interfaces. 2012; 4(8):3888-92. DOI: 10.1021/am301237j. View

16.

Huling J, Ko I, Atala A, Yoo J . Fabrication of biomimetic vascular scaffolds for 3D tissue constructs using vascular corrosion casts. Acta Biomater. 2016; 32:190-197. DOI: 10.1016/j.actbio.2016.01.005. View

17.

Song J, Guyette J, Gilpin S, Gonzalez G, Vacanti J, Ott H . Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med. 2013; 19(5):646-51. PMC: 3650107. DOI: 10.1038/nm.3154. View

18.

Tanaka N, Ota H, Fukumori K, Miyake J, Yamato M, Okano T . Micro-patterned cell-sheets fabricated with stamping-force-controlled micro-contact printing. Biomaterials. 2014; 35(37):9802-9810. DOI: 10.1016/j.biomaterials.2014.08.043. View

19.

Auletta J, Eid S, Wuttisarnwattana P, Silva I, Metheny L, Keller M . Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. Stem Cells. 2014; 33(2):601-14. PMC: 4304927. DOI: 10.1002/stem.1867. View

20.

Caplan A, Correa D . The MSC: an injury drugstore. Cell Stem Cell. 2011; 9(1):11-5. PMC: 3144500. DOI: 10.1016/j.stem.2011.06.008. View